BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute

(BIOCAD) On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD becomes an industrial partner of the scientific center and will ensure the mass-scale production of the «Sputnik V vaccine.